Serum HSP47 is a novel blood marker for rapidly progressive interstitial pneumonia

T. Kakugawa, S. I. Yokota, Y. Ishimatsu, T. Hayashi, S. Nakashima, S. Hara, N. Sakamoto, H. Kubota, M. Mine, Y. Matsuoka, H. Mukae, K. Nagata, S. Kohno (Nagasaki, Sapporo, Kyoto, Akita, Kitakyushu, Japan)

Source: Annual Congress 2011 - The ageing pulmonary interstitium
Session: The ageing pulmonary interstitium
Session type: Thematic Poster Session
Number: 781
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Kakugawa, S. I. Yokota, Y. Ishimatsu, T. Hayashi, S. Nakashima, S. Hara, N. Sakamoto, H. Kubota, M. Mine, Y. Matsuoka, H. Mukae, K. Nagata, S. Kohno (Nagasaki, Sapporo, Kyoto, Akita, Kitakyushu, Japan). Serum HSP47 is a novel blood marker for rapidly progressive interstitial pneumonia. Eur Respir J 2011; 38: Suppl. 55, 781

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
KL-6/MUC1 in interstitial pneumonia
Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases
Year: 2005

Serum napsin A is a novel diagnostic and monitoring marker for interstitial lung disease
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011

Usefulness of serum bird specific antibody levels in patients with interstitial pneumonia
Source: International Congress 2016 – Orphan diseases II
Year: 2016

Surfactant proteins in interstitial pneumonia
Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases
Year: 2005

Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

Elevated levels of serum SP-A in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001

Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
Source: Eur Respir J 2011; 37: 1119-1127
Year: 2011



Human napsin a is a useful serum marker of interstitial lung disease, compared to KL-6, and surfactant protein-D
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Elevated levels of BALF galectin-9 in patients with interstitial pneumonia
Source: Annual Congress 2009 - Airways remodelling
Year: 2009

Serum chitotriosidase levels in granulomatous lung disorders
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

A clinicopathological review of interstitial pneumonia with marked IgG4 positive plasma cells infiltration
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012

Elevation of serum tumor markers in patients with interstitial lung disease
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Increased cytokeratin-19 expression in fibrotic interstitial lung disease
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Serum IGFBP2 as a marker of idiopathic pulmonary fibrosis
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015


Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


KL-6 is a useful serum biomarker for early detection of interstitial lung disease
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012